Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513156 · ClinicalTrials.gov registry record · NA
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
A NA study of Opioid Use Disorder and Stimulant Use Disorder, sponsored by Elana Rosenthal.
- Recruiting
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 4
- Study locations
NCT06513156 is a NA study of Opioid Use Disorder and Stimulant Use Disorder that is actively recruiting participants, run by Elana Rosenthal. The registered enrollment target is 304 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06513156, a NA study of Opioid Use Disorder and Stimulant Use Disorder, is actively recruiting participants, sponsored by Elana Rosenthal.
- RECRUITING
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.
Conditions Studied
Interventions
- BEHAVIORAL Integrated Infectious Diseases and Substance Use Disorder Clinic (IC)
Study Locations (4)
District of Columbia
- George Washington University - Washington D.C.
Georgia
- Emory University - Atlanta
Maryland
- University of Maryland Baltimore - Baltimore
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06513156
The ClinicalTrials.gov registry entry for NCT06513156 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Elana Rosenthal, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) is the first listed.
NCT06513156 reports 4 study locations spanning 4 distinct geographic areas - top geographies include District of Columbia, Georgia, Maryland.
Frequently Asked Questions
What is clinical trial NCT06513156 about?
NCT06513156 is a clinical study titled "Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use". This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improv...
What is the current status of trial NCT06513156?
This trial is currently recruiting. It is a NA study. The enrollment target is 304 participants. The study started on 2024-10-01. Estimated completion is 2027-07-30.
What conditions does trial NCT06513156 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Stimulant Use Disorder, Injection Related Infections.
What interventions are being tested in trial NCT06513156?
The interventions under investigation include: Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06513156?
This trial is sponsored by Elana Rosenthal, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513156 being conducted?
This trial has 4 study locations across District of Columbia, Georgia, Maryland, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Opioid Use Disorder
All registered trials for this condition
Stimulant Use Disorder
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.